11 results about "Garcinia" patented technology

The invention discloses a composition with effects of losing weight and reducing blood fat. Every 100g of the composition comprises the following components and contents: (1) 10-30mg of adiponectin functional fragments; (2) 5 to 15 mg of PCSK9 inhibitory peptide; (3) 1-5 g of a radix puerariae extract; (4) 1-3 g of garcinia cambogia extract; (5) 0.5-2 g of a green coffee bean extract; (6) 1 to 3g of microencapsulated fish oil; (7) 0.5 to 1g of chitosan; and 5 to 10 g of erythritol. Through the synergistic effect of various bioactive components, the composition can effectively reduce fat accumulation and reduce the blood fat level, and meanwhile has good taste and use convenience. The composition disclosed by the invention provides an innovative solution for losing weight and reducing blood fat, and has potential clinical and commercial application values.

The invention relates to a method for preparing thiogambogic bacteria by utilizing a streptomyces deserticola new strain, which comprises the following steps: (1) activating: inoculating a yeast starch solid culture medium with the streptomyces deserticola new strain Streptomyces sp. HMX112 preserved at-80 DEG C in a streak manner, and culturing at 30 DEG C for 14 days to obtain activated pure culture strain HMX112 spores; (2) seed culture: inoculating activated pure culture strain HMX112 spores into a casein tryptone liquid culture medium, and performing shake cultivation to obtain a first-stage seed solution; (3) fermentation culture: inoculating the first-grade seed liquid into a Gause No.1 liquid fermentation culture medium, and carrying out shake culture to obtain fermentation liquid; (4) fermentation liquor treatment: pre-cooling the fermentation liquor at 4 DEG C, then carrying out solid-liquid separation, and repeatedly extracting and concentrating the obtained supernatant for more than three times by using isometric ethyl acetate to obtain a crude extract; and (5) preparing the sulfur garcinia. The preparation method is simple, and the sample purity is high.

The invention provides a composition comprising a plant or fungal extract in combination with a phenol compound. Such a composition is for use in reducing lipid levels in sebocytes, and the composition may find use in treating acne vulgaris and rosacea. The composition may comprise (a) a phenol compound according to formula (I), or a pharmaceutically or cosmetically acceptable salt, prodrug, solvate, tautomer or stereoisomer thereof; and (b) a plant or fungal extract selected from extracts of plants belonging to the genus Arctostaphylos, Fragaria, Garcinia, Hedera, Ilex, and Rubus, and extracts of the fungus Wolfiporia, (I) where each of R1 to R5 and -L- are as described herein.

The invention discloses a xanthone compound as well as a preparation method and application thereof, the xanthone compound is obtained by taking stems and leaves of dry luteaceae Piper plant Piper as a raw material through extract extraction, organic solvent extraction, silica gel column chromatography and high-pressure liquid chromatography separation, and the molecular formula of the xanthone compound is C28H32O8 or C23H24O5. The xanthone compound can be used for preparing an alpha-glucosidase inhibitor. According to an alpha-glucosidase inhibitory activity experiment, acarbose is selected as a positive control, the IC50 values of the two xanthone compounds to alpha-glucosidase are 23.12 [mu] mol / L and 3.6 [mu] mol / L respectively, and both the xanthone compounds have good alpha-glucosidase inhibitory activity. The compound disclosed by the invention is simple in structure and good in activity, can be used as a pilot compound of an anti-diabetic drug, and has a good application prospect.

Food supplement characterized by containing an active ingredient consisting of - 18 to 19 wt% green tea extract, of which 45 to 55 wt% of this extract consists of polyphenols and 6 to 7 wt% of this extract consists of theine, - 18 to 19% w / w extract from Cambodian Garcinia 10:1, - 14 to 15 wt% extract from red Moro orange 20:1, - 14 to 15 wt% extract from Gymnema sylvestre, of which 25 wt% of this extract consists of gymnemic acids, - 7 to 8 wt% extract of Coleus forskohlii, of which 5 wt% of this extract consists of forskolin, - 7 to 8% by weight berberine from Indian barberry, - 7 to 8% w / w extract from Paraguayan holly 10:1, - 7 to 8% w / w extract of fenugreek 10:1, - 3 to 4 wt% saffron extract, of which 0.1 to 0.2 wt% this extract consists of safranal, and max. 0.005 wt% chromium.

The present invention relates to the field of natural medicine technology, and specifically to a caged ketone compound extracted from Garcinia macrobracte leaves, as well as a preparation method and use thereof. An insulin resistance model was established by inducing HepG2 cells with palmitic acid, and the hypoglycemic activity of the compound was tested using an in vitro glucose oxidase method. The results showed that the caged ketone compound could significantly increase glucose consumption in HepG2-IR cells and improve the insulin resistance state of HepG2-IR cells to varying degrees. In vitro anti-proliferative activity experiments showed that the caged ketone compound had significant anti-A549 cell proliferation activity. The present invention provides alternative compounds for the development of new hypoglycemic and anti-tumor drugs, which is of great significance to the comprehensive development and utilization of Garcinia macrobracte leaves.

Described herein are compositions and methods that modulate or enhance the taste perceptions of a subject. Aspects of the present disclosure relate to compositions and methods of use comprising a flavonolignan, a steroid saponin, an iridoid glycoside, amentoflavone, a polyisoprenylated benzophenone, a phenylpropanoid, a pheylethanol derivate, a glycoside and / or analogs thereof (for example, a glycosylation molecule of an aglycone, an aglycone of a glycosylated molecule, or a further glycosylated molecule of a glycosylated molecule) obtained from a plant extract such as a Silybum marianum (milk thistle) extract, an Asparagus racemosus extract, a Smilax china extract, a Rehmannia glutinosa root extract, a Selaginella tamariscina extract, a Garcinia indicia extract, a Garcinia cambogia extract, a Trigonella foenum graecum L. extract, a Rhodiola rosea root or rhizome extract and / or other plant sources which are used for enhancing a subject's taste perception of sweetness, mouthfeel, astringency, bitterness, alcohol, carbonation, spice, salt, sourness, umami, tingling, numbing or cooling, harshness, pungency, burning, freshness, ripeness, juiciness, for increasing the amount of carbonation bubbles or decreasing the carbonation bubble size of a carbonated beverage, or for masking off-tastes

The present invention provides a composition for reducing lipid production in sebaceous gland cells or in the skin of a subject, the composition comprising a triterpenoid according to Formula (I) as described herein or a pharmaceutically or cosmetically acceptable salt, prodrug, solvate, tautomer or stereoisomer thereof; and a plant extract selected from extracts of plants of the genus Garcinia, Rubus, Strawberry, Ilex and Hedera.

The invention belongs to the technical field of natural medicine extraction, and particularly discloses a method for extracting caulis spatholobi flavone through ultrasonic and microwave synergy, which comprises the following steps: sieving a caulis spatholobi medicinal material with a 60-mesh sieve to obtain medicinal material powder, mixing the medicinal material powder with a 50% ethanol solution, performing ultrasonic-microwave extraction, filtering, merging and collecting filtrate, and performing vacuum concentration to obtain the caulis spatholobi flavone. The invention also discloses a preparation method of the caulis spatholobi flavone extracted by the method, and provides an extraction method which is time-consuming, less in generated waste liquid and higher in flavone extraction rate.

The present invention provides compositions comprising a combination of a plant or fungal extract and a phenolic compound. Such compositions are useful for reducing lipid levels in sebocytes, and the compositions can be used to treat acne vulgaris and rosacea. The compositions can comprise: (a) a phenolic compound according to Formula (I) or a pharmaceutically or cosmetically acceptable salt, prodrug, solvate, tautomer, or stereoisomer thereof; and (b) a plant or fungal extract selected from the group consisting of extracts of plants belonging to the genera Arctostaphylos, Fragaria, Garcinia, Hedera, Ilex, and Rubus, and extracts of the fungal genus Poria, wherein R 1 to R 5 and -L- are each as described herein.

The invention provides a composition for use in decreasing lipid production in sebocytes or in the skin of an individual, where the composition includes a triterpenoid compound as shown in formula (I), as described herein, or a pharmaceutically or cosmetically acceptable salt, prodrug, solvate, tautomer or stereoisomer thereof; and a plant extract selected from extracts of plants belonging to the genus Garcinia, Rubus, Fragaria, Ilex and Hedera.